Advisor Group’s Actinium Pharmaceuticals ATNM Stock Holding History

Advisor Group’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$14K	Sell	2,174 -30	-1%	-$207	﹤0.01%	4135
2019 Q3	$15K	Sell	2,204 -76	-3%	-$529	﹤0.01%	4116
2019 Q2	$17K	Hold	2,280	–	–	﹤0.01%	4062
2019 Q1	$33K	Sell	2,280 -453	-17%	-$7.23K	﹤0.01%	3660
2018 Q4	$32K	Buy	2,733 +521	+24%	+$8.89K	﹤0.01%	3493
2018 Q3	$49K	Buy	+2,212	New	+$45K	﹤0.01%	3302
2018 Q1	–	Sell	-133	Closed	-$3K	–	4940
2017 Q4	$3K	Hold	133	–	–	﹤0.01%	4554
2017 Q3	$2K	Hold	133	–	–	﹤0.01%	4519
2017 Q2	$5K	Hold	133	–	–	﹤0.01%	4212
2017 Q1	$6K	Sell	133 -70	-34%	-$2.69K	﹤0.01%	4016
2016 Q4	$5K	Buy	203 +133	+190%	+$4.16K	﹤0.01%	3913
2016 Q3	$3K	Hold	70	–	–	﹤0.01%	4048
2016 Q2	$3K	Buy	+70	New	+$3.91K	﹤0.01%	3953

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Advisor Group's ATNM Position: Q4 2019 in Review

Advisor Group reduced its Actinium Pharmaceuticals (ATNM) stake by 1.4% in Q4 2019, selling an estimated $207 and leaving 2,174 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #4135.

Advisor Group first reported a position in ATNM in Q2 2016 and has held it in 13 quarters since. The position peaked at $49K in Q3 2018. 45 funds tracked by Wall St. Rank hold ATNM as of Q4 2019.

Advisor Group held 2,174 shares of Actinium Pharmaceuticals worth $14K as of Q4 2019.
Advisor Group sold 30 Actinium Pharmaceuticals shares in Q4 2019, an estimated $207.
Actinium Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4135 holding.
Advisor Group first reported a position in Actinium Pharmaceuticals in Q2 2016 and has held it in 13 quarters since.
Advisor Group's Actinium Pharmaceuticals position peaked at $49K in Q3 2018.
45 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.